Reuters: Health
GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.
GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments
GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments
Reuters: Health
GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.
Reuters: Health
GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment